Coloplast A/S (CLPBF)
74.24
-0.08
(-0.10%)
USD |
OTCM |
Nov 18, 16:00
Coloplast Price to Book Value : 7.705 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 7.705 |
| November 17, 2026 | 7.713 |
| November 16, 2026 | 7.825 |
| November 13, 2026 | 7.743 |
| November 12, 2026 | 7.658 |
| November 11, 2026 | 7.658 |
| November 10, 2026 | 7.529 |
| November 09, 2026 | 7.825 |
| November 06, 2026 | 7.545 |
| November 05, 2026 | 7.545 |
| November 04, 2026 | 7.545 |
| November 03, 2026 | 7.545 |
| November 02, 2026 | 7.188 |
| October 30, 2026 | 7.393 |
| October 29, 2026 | 7.393 |
| October 28, 2026 | 7.267 |
| October 27, 2026 | 7.267 |
| October 26, 2026 | 7.267 |
| October 23, 2026 | 7.267 |
| October 22, 2026 | 7.267 |
| October 21, 2026 | 7.267 |
| October 20, 2026 | 7.267 |
| October 19, 2026 | 7.282 |
| October 16, 2026 | 7.282 |
| October 15, 2026 | 7.282 |
| Date | Value |
|---|---|
| October 14, 2026 | 6.395 |
| October 13, 2026 | 6.395 |
| October 12, 2026 | 6.395 |
| October 09, 2026 | 6.395 |
| October 08, 2026 | 6.395 |
| October 07, 2026 | 6.395 |
| October 06, 2026 | 6.395 |
| October 05, 2026 | 6.518 |
| October 02, 2026 | 6.518 |
| October 01, 2026 | 6.518 |
| September 30, 2026 | 6.518 |
| September 29, 2026 | 6.924 |
| September 28, 2026 | 6.924 |
| September 25, 2026 | 6.924 |
| September 24, 2026 | 6.924 |
| September 23, 2026 | 6.924 |
| September 22, 2026 | 6.924 |
| September 21, 2026 | 6.924 |
| September 18, 2026 | 6.867 |
| September 17, 2026 | 6.867 |
| September 16, 2026 | 6.867 |
| September 15, 2026 | 7.532 |
| September 14, 2026 | 7.532 |
| September 11, 2026 | 7.532 |
| September 10, 2026 | 7.532 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ambu A/S | 3.650 |
| Abbott Laboratories | 3.528 |
| AngioDynamics, Inc. | 2.782 |
| Alphatec Holdings, Inc. | -- |
| AtriCure, Inc. | 5.165 |
Price to Book Value Related Metrics
| PE Ratio | 35.18 |
| PS Ratio | 3.719 |
| Price to Free Cash Flow | 16.89 |
| Price | 74.24 |
| Earnings Yield | 2.84% |
| Market Cap | 16.73B |
| Operating PE Ratio | 14.61 |
| Normalized PE Ratio | 20.55 |